• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期与标准全身[镓]Ga-PSMA-11在生化复发前列腺癌中的临床性能比较。

Comparison of clinical performance between late and standard total-body [ Ga]Ga-PSMA-11 in biochemical recurrent prostate cancer.

作者信息

Chen Qiaochu, Dong Liang, Xu Lian, Zhao Haitao, Li Lianghua, Huang Gang, Liu Jianjun, Chen Ruohua

机构信息

Department of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.

Department of Urology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Eur J Nucl Med Mol Imaging. 2025 Mar;52(4):1249-1256. doi: 10.1007/s00259-024-06980-8. Epub 2024 Nov 14.

DOI:10.1007/s00259-024-06980-8
PMID:39540904
Abstract

BACKGROUND AND PURPOSE

Enhanced lesion detection in prostate cancer is observed with late [ Ga]Ga-PSMA-11 PET/CT imaging compared to standard [ Ga]Ga-PSMA-11 PET/CT imaging (50-100 min p.i.). However, the poor image quality of late imaging using short axial field of view (SAFOV) PET/CT has hindered its sole clinical adoption. Conversely, the image quality of late imaging with a long axial field of view (LAFOV) [ Ga]Ga-PSMA-11 PET/CT fulfills clinical diagnostic requirements. Nonetheless, the diagnostic efficacy of late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis and its impact on treatment decisions, compared to standard LAFOV [ Ga]Ga-PSMA-11 PET/CT, remains unclear. This study aims to compare the rate of PET positivity between late and standard LAFOV [ Ga]Ga-PSMA-11 PET/CT and to evaluate the influence of late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis on treatment decisions relative to standard scans.

METHODS

From January 2021 to April 2024, 127 patients with biochemical recurrence of prostate cancer post-radical prostatectomy were enrolled to undergo both standard and late LAFOV [ Ga]Ga-PSMA-11 PET/CT scans at Shanghai Renji Hospital. We compared the rate of PET positivity between the two modalities at the patient level and across different anatomical regions. We assessed the added diagnostic value of late LAFOV [ Ga]Ga-PSMA-11 PET/CT and its impact on modifying patient treatment plans.

RESULTS

The image quality of late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis in all patients met clinical diagnostic requirements. The rate of PET positivity of late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis were significantly higher than those of standard LAFOV [ Ga]Ga-PSMA-11 PET/CT (80.31% [102/127] vs. 65.35% [83/127]; P < 0.001). Late LAFOV [ Ga]Ga-PSMA-11 PET/CT demonstrated higher lesion SUVmax (16.69 ± 16.42 vs. 11.91 ± 10.72, P < 0.001) and TBR (6.26 ± 7.21 vs. 3.44 ± 3.57, P < 0.001) compared to standard LAFOV scans. Additionally, 14.17% (18/127) of patients experienced changes in their treatment regimen due to the superior detection capabilities of late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis compared to the standard scan.

CONCLUSIONS

The rate of PET positivity of late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis compared to standard LAFOV [ Ga]Ga-PSMA-11 PET/CT highlight its potential as a valuable diagnostic tool for biochemically recurrent prostate cancer. This study paves the way for using late LAFOV [ Ga]Ga-PSMA-11 PET/CT with forced diuresis for prostate cancer imaging in daily clinical practice, facilitating more accurate and timely diagnoses.

摘要

背景与目的

与标准的[镓]镓-PSMA-11 PET/CT成像(注射后50 - 100分钟)相比,延迟[镓]镓-PSMA-11 PET/CT成像可提高前列腺癌病灶的检测率。然而,使用短轴视野(SAFOV)PET/CT进行延迟成像时图像质量较差,阻碍了其在临床中的单独应用。相反,长轴视野(LAFOV)[镓]镓-PSMA-11 PET/CT的延迟成像质量满足临床诊断要求。尽管如此,与标准LAFOV[镓]镓-PSMA-11 PET/CT相比,延迟LAFOV[镓]镓-PSMA-11 PET/CT在强制利尿情况下的诊断效能及其对治疗决策的影响仍不明确。本研究旨在比较延迟和标准LAFOV[镓]镓-PSMA-11 PET/CT的PET阳性率,并评估延迟LAFOV[镓]镓-PSMA-11 PET/CT在强制利尿情况下相对于标准扫描对治疗决策的影响。

方法

2021年1月至2024年4月,127例前列腺癌根治术后生化复发的患者在上海仁济医院接受标准和延迟LAFOV[镓]镓-PSMA-11 PET/CT扫描。我们在患者层面和不同解剖区域比较了两种模式下的PET阳性率。我们评估了延迟LAFOV[镓]镓-PSMA-11 PET/CT的附加诊断价值及其对修改患者治疗计划的影响。

结果

所有患者在强制利尿情况下延迟LAFOV[镓]镓-PSMA-11 PET/CT的图像质量均满足临床诊断要求。延迟LAFOV[镓]镓-PSMA-11 PET/CT在强制利尿情况下的PET阳性率显著高于标准LAFOV[镓]镓-PSMA-11 PET/CT(80.31%[102/127]对65.35%[83/127];P<0.001)。与标准LAFOV扫描相比,延迟LAFOV[镓]镓-PSMA-11 PET/CT显示出更高的病灶SUVmax(16.69±16.42对11.91±10.72,P<0.001)和TBR(6.26±7.21对3.44±3.57,P<0.001)。此外,14.17%(18/127)的患者由于延迟LAFOV[镓]镓-PSMA-11 PET/CT在强制利尿情况下比标准扫描具有更强的检测能力,其治疗方案发生了改变。

结论

与标准LAFOV[镓]镓-PSMA-11 PET/CT相比,延迟LAFOV[镓]镓-PSMA-11 PET/CT在强制利尿情况下的PET阳性率突出了其作为生化复发前列腺癌有价值诊断工具的潜力。本研究为在日常临床实践中使用延迟LAFOV[镓]镓-PSMA-11 PET/CT进行强制利尿的前列腺癌成像铺平了道路,有助于更准确、及时地进行诊断。

相似文献

1
Comparison of clinical performance between late and standard total-body [ Ga]Ga-PSMA-11 in biochemical recurrent prostate cancer.晚期与标准全身[镓]Ga-PSMA-11在生化复发前列腺癌中的临床性能比较。
Eur J Nucl Med Mol Imaging. 2025 Mar;52(4):1249-1256. doi: 10.1007/s00259-024-06980-8. Epub 2024 Nov 14.
2
The superior detection rate of total-body [Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy.全身 [Ga]Ga-PSMA-11 PET/CT 比短轴向视野 [Ga]Ga-PSMA-11 PET/CT 对根治性前列腺切除术后 PSA<0.2ng/mL 的早期复发性前列腺癌患者的检测率更高。
Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2484-2494. doi: 10.1007/s00259-024-06674-1. Epub 2024 Mar 22.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Combined forced diuresis and late acquisition on [Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study.[68Ga]Ga-PSMA-11 PET/CT 延迟采集联合强力利尿在生化复发前列腺癌中的应用:一项临床实用导向的研究。
Eur Radiol. 2023 May;33(5):3343-3353. doi: 10.1007/s00330-023-09516-0. Epub 2023 Mar 9.
5
Combination of Forced Diuresis with Additional Late Imaging in Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake.镓-PSMA-11 PET/CT 中联合强制利尿和后期显像:对病灶显示和放射性示踪剂摄取的影响。
J Nucl Med. 2021 Sep 1;62(9):1252-1257. doi: 10.2967/jnumed.120.257741. Epub 2021 Feb 5.
6
Whole-Body Integrated [Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.全身整合 [Ga]PSMA-11-PET/MR 成像在复发性前列腺癌患者中的应用:与全身 PET/CT 作为参考标准的比较。
Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.
7
Total-body PET/CT with half-dose [ Ga]Ga-PSMA-11 for biochemical recurrent prostate cancer: comparable diagnostic value to short axial field-of-view PET/CT with full-dose [ Ga]Ga-PSMA-11.全身 PET/CT 半剂量 [Ga]Ga-PSMA-11 检测前列腺癌生化复发:与短轴向视野全剂量 [Ga]Ga-PSMA-11 PET/CT 相比具有相当的诊断价值。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):581-589. doi: 10.1007/s00259-023-06466-z. Epub 2023 Oct 11.
8
Total-body [ Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [ Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer.全身 [68Ga]Ga-PSMA-11 PET/CT 与常规 [68Ga]Ga-PSMA-11 PET/CT 相比,可提高生化复发性前列腺癌患者的检出率。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4096-4106. doi: 10.1007/s00259-023-06355-5. Epub 2023 Aug 14.
9
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for Ga-PSMA-11 PET/CT.早期注射呋塞米可提高 Ga-PSMA-11 PET/CT 检查疑似生化复发前列腺癌患者局部复发的检出率。
J Nucl Med. 2021 Nov;62(11):1550-1557. doi: 10.2967/jnumed.120.261866. Epub 2021 Mar 12.
10
F-fluciclovine PET-CT and Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.氟[¹⁸F]氟代脱氧葡萄糖 PET-CT 和镓[⁶⁸Ga]前列腺特异性膜抗原-11 PET-CT 在前列腺癌根治术后早期生化复发患者中的应用:一项前瞻性、单中心、单臂、对比成像试验。
Lancet Oncol. 2019 Sep;20(9):1286-1294. doi: 10.1016/S1470-2045(19)30415-2. Epub 2019 Jul 30.

引用本文的文献

1
Bladder activity of different PSMA PET radioligands and impact of furosemide.不同前列腺特异性膜抗原(PSMA)正电子发射断层扫描(PET)放射性配体的膀胱活性及呋塞米的影响
Res Sq. 2025 May 8:rs.3.rs-6537072. doi: 10.21203/rs.3.rs-6537072/v1.

本文引用的文献

1
PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描双时相成像:可有可无还是不可或缺?
J Nucl Med. 2024 May 1;65(5):818-819. doi: 10.2967/jnumed.123.266722.
2
Impact of forced diuresis at two different time points on pelvic imaging in prostatic carcinoma with 68 Ga-PSMA PET/CT.68Ga-PSMA PET/CT 指导下不同时间点强制利尿对前列腺癌盆腔成像的影响。
Nucl Med Commun. 2023 Dec 1;44(12):1135-1143. doi: 10.1097/MNM.0000000000001771. Epub 2023 Oct 5.
3
Total-body [ Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [ Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer.
全身 [68Ga]Ga-PSMA-11 PET/CT 与常规 [68Ga]Ga-PSMA-11 PET/CT 相比,可提高生化复发性前列腺癌患者的检出率。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4096-4106. doi: 10.1007/s00259-023-06355-5. Epub 2023 Aug 14.
4
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.PSMA PET/CT:前列腺癌成像 2.0 的 EANM 程序指南/ SNMMI 程序标准联合。
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486. doi: 10.1007/s00259-022-06089-w. Epub 2023 Jan 5.
5
Oligometastatic Prostate Cancer: Current Status and Future Challenges.寡转移前列腺癌:现状与未来挑战。
J Nucl Med. 2022 Nov;63(11):1628-1635. doi: 10.2967/jnumed.121.263124.
6
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.寡转移前列腺癌转移灶定向治疗与观察的长期结局和反应的遗传预测:STOMP 和 ORIOLE 试验分析。
J Clin Oncol. 2022 Oct 10;40(29):3377-3382. doi: 10.1200/JCO.22.00644. Epub 2022 Aug 24.
7
Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer-first clinical experiences.使用长轴向视野 PET/CT 扫描仪进行晚期采集[68Ga]Ga-PSMA-11 PET/CT 对复发性前列腺癌诊断的可行性:初步临床经验。
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4456-4462. doi: 10.1007/s00259-021-05438-5. Epub 2021 Jun 21.
8
Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for Ga-PSMA-11 PET/CT.早期注射呋塞米可提高 Ga-PSMA-11 PET/CT 检查疑似生化复发前列腺癌患者局部复发的检出率。
J Nucl Med. 2021 Nov;62(11):1550-1557. doi: 10.2967/jnumed.120.261866. Epub 2021 Mar 12.
9
Combination of Forced Diuresis with Additional Late Imaging in Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake.镓-PSMA-11 PET/CT 中联合强制利尿和后期显像:对病灶显示和放射性示踪剂摄取的影响。
J Nucl Med. 2021 Sep 1;62(9):1252-1257. doi: 10.2967/jnumed.120.257741. Epub 2021 Feb 5.
10
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View.基于 NEMA NU 2-2018 对 uEXPLORER 全身 PET/CT 扫描仪进行性能评估,并用额外的测试来对长轴向视野的 PET 扫描仪进行特性描述。
J Nucl Med. 2021 Jun 1;62(6):861-870. doi: 10.2967/jnumed.120.250597. Epub 2020 Oct 2.